Global Injectable Drug Delivery Market Forecast to 2024 - A report by Data Bridge Market Research

Global Injectable Drug Delivery Market, By Type (Devices (Conventional Injection Devices, Self Injection Devices), Formulations (Conventional Drug Delivery, Noble Drug Delivery, Long Acting Injection Formulations), By Applications (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Oncology, Others), By Usage Pattern (Curative Care, Immunizations, Other Usage Patterns), By Mode of Administration (Skin, Circulatory, Organs, Central Nervous System), By End User (Hospitals, Clinics, Home Care Settings, Research Laboratories, Pharma & Biotech Companies), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) – Industry Trends and Forecast to 2024

Global Injectable Drug Delivery Market is expected to reach USD 789.7 billion by 2024 from USD 330.6 billion in 2016, growing at a CAGR of 11.5% in the forecast period 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

The market is segmented based on type, applications, usage pattern, mode of administration, end user and geography.

Request a sample pages: http://databridgemarketresearch.com/reports/global-injectable-drug-delivery-market/

Based on type the market is segmented into Devices and Formulation. In 2017, the market is expected to dominate by the formulations segment with highest market share and is also expected to grow at the highest CAGR in the forecasted period 2017 to 2024.

On the basis of applications, the market is segmented into hormonal disorders, oncology, autoimmune diseases, orphan diseases, and others.

Based on usage pattern the market is segmented into curative care, immunization, and others.

On the basis of mode of administration the market is segmented into skin, circulatory, organs and central nervous system. Administration through skin is the most common and the highest growing segment in the forecast period 2017 to 2024.

Based on geography, the injectable drug delivery market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Rest of the world. In 2017, North America is expected to account for the largest share of this market, followed by Europe. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.

Read more about the report: http://databridgemarketresearch.com/global-injectable-drug-delivery-market-poised-reach-usd-797-2-billion-2024/

The key players operating in this market are Baxter International, Inc., Becton, Dickinson and Company, Gerresheimer AG, Pfizer, Inc., Schott AG, Alkermes Plc., Eli Lilly and Company, Sandoz, Terumo Corporation, and Teva Pharmaceuticals Industries Ltd. among other vernacular players.

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge Market Research
Office Number 317, Amanora Chambers,
Magarpatta Road, Hadapsar
Pune – 411028
Maharashtra, India
Toll Free: +1-888-387-2818
Mail: sales@databridgemarketresearch.com

This release was published on openPR.